Results 191 to 200 of about 2,229,234 (312)

Multi‐Class Blood Cancer Malignancy Prediction From Microscopic Blood Cell Images Using ShuffleNetV2

open access: yesVector: The Journal of Engineering, Volume 2027, Issue 1, January/December 2027.
A lightweight ShuffleNetV2‐based deep learning model is proposed for multi‐class blood cancer classification using microscopic blood cell images. The model achieves 95.69% accuracy and 0.9979 AUC while maintaining low computational cost, demonstrating its suitability for efficient clinical diagnostic support in resource‐constrained environments ...
Muhammad Azam Rasheed   +7 more
wiley   +1 more source

Minor Myeloid Leukemic Populations in Pediatric Acute Lymphoblastic Leukemia: A Potentially Underrecognized Mixed-Phenotype Tumor? [PDF]

open access: yesInt J Mol Sci
Semchenkova A   +11 more
europepmc   +1 more source

A Novel NR3C1 Frameshift Variant Associated With Familial Glucocorticoid Resistance Syndrome: An Integrated Analysis of Steroid Profiling and Structural Modeling

open access: yesAmerican Journal of Medical Genetics Part A, Volume 200, Issue 12, Page 2719-2737, December 2026.
ABSTRACT Glucocorticoid resistance syndrome (GRS) is a rare hereditary disorder caused by pathogenic variants in NR3C1, characterized by marked phenotypic heterogeneity and frequent misdiagnosis as primary aldosteronism or subclinical Cushing's syndrome.
Sufang Yun   +7 more
wiley   +1 more source

Extreme Thrombocytosis in Patients With Malignancy; Complications, Management and Outcomes

open access: yeseJHaem, Volume 7, Issue 6, December 2026.
ABSTRACT Introduction Extreme thrombocytosis (EXT; platelet count >1000 × 109/L) is a rare haematological abnormality that may be primary or reactive. Data on its incidence and management in patients with malignancy are limited. We retrospectively evaluated the incidence, management, and complications of EXT in patients with malignancy over a 12‐year ...
Laura McDonald   +8 more
wiley   +1 more source

Characteristics and Hospital Outcomes of Patients Admitted to the Intensive Care Unit Because of Haematological Malignancy—A Service Evaluation

open access: yeseJHaem, Volume 7, Issue 6, December 2026.
ABSTRACT Introduction Intensive care unit (ICU) admission due to haematological malignancy (HM) has previously been questioned due to high mortality. While mortality‐associated factors have been studied in HM patients to guide decision making and clinical practice, UK‐based research remains limited.
Adam Harriman   +4 more
wiley   +1 more source

β‐Arrestin1 Promotes Prostate Cancer Progression via Modulating ESRP1‐Mediated Alternative Splicing of CD44

open access: yesMedComm – Oncology, Volume 5, Issue 4, December 2026.
β‐arrestin1 promotes prostate cancer progression by suppressing epithelial splicing regulatory protein 1 (ESRP1) expression and shifting CD44 alternative splicing toward CD44s and away from CD44v2 and CD44v6. These changes accompany increased N‐cadherin, decreased E‐cadherin, and enhanced epithelial–mesenchymal transition.
Sicheng Dong   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy